Serotonin Syndrome Latest Advances

Cross-national differences in methylphenidate utilization in primarily adult psychiatric inpatients.

Journal: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

Published: January 07, 2026

The evolving serotonin syndrome spectrum: from acute syndrome to smoldering presentations and personalized risk management.

Journal: Expert opinion on drug metabolism & toxicology

Published: December 24, 2025

Serotonin Syndrome With Quetiapine, Rizatriptan, Gabapentin, and Propranolol.

Journal: The primary care companion for CNS disorders

Published: December 10, 2025

Carisoprodol poisoning with serotonin toxicity.

Journal: BMJ case reports

Published: December 08, 2025

Time Course of Serum Dextromethorphan Concentrations in a Case of Serotonin Syndrome After Massive Overdose.

Journal: The American journal of case reports

Published: December 05, 2025

Evaluation of clinical findings in predicting the development of serotonin syndrome: can the Hunter's criteria be used in children?

Journal: Postgraduate medicine

Published: November 21, 2025

Title Not Found

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: November 06, 2025

Triggers of highly lethal seizures induced by novel stimulants: A systematic review focused on synthetic cathinones and phenethylamines.

Journal: Neurotoxicology

Published: October 30, 2025

Knowledge, attitudes, and practices toward linezolid-serotonergic drug interactions: a cross-sectional study.

Journal: Frontiers in pharmacology

Published: October 09, 2025

Delayed Serotonin Syndrome Following the Concurrent Use of an Unregulated Supplement and Selective Serotonin Reuptake Inhibitors (SSRIs): A Case Report.

Journal: Cureus

Published: October 03, 2025

Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders.

Journal: Expert opinion on drug metabolism & toxicology

Published: September 25, 2025

Polypharmacy-induced serotonin syndrome revealing underlying neurocognitive impairment and cervical myelopathy.

Journal: BMJ case reports

Published: September 25, 2025